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Abstract The purpose of this study was to examine the
incidence of new or recurrent venous thromboembolism
(VTE) after retrieval of inferior vena cava (IVC) ﬁlters and
risk factors associated with such recurrence. Between
March 2001 and September 2008, at our institution,
implanted retrievable vena cava ﬁlters were retrieved in 76
patients. The incidence of new or recurrent VTE after
retrieval was reviewed and numerous variables were ana-
lyzed to assess risk factors for redevelopment of VTE after
ﬁlter retrieval. In 5 (6.6%) of the 76 patients, redevelop-
ment or worsening of VTE was seen after retrieval of the
ﬁlter. Three patients (4.0%) had recurrent deep venous
thrombosis (DVT) in the lower extremities and 2 (2.6%)
had development of pulmonary embolism, resulting in
death. Although there was no signiﬁcant difference in the
incidence of new or recurrent VTE related to any risk
factor investigated, a tendency for development of VTE
after ﬁlter retrieval was higher in patients in whom DVT in
the lower extremities had been so severe during ﬁlter
implantation that interventional radiological therapies in
addition to traditional anticoagulation therapies were
required (40% in patients with recurrent VTE vs. 23% in
those without VTE; p = 0.5866 according to Fisher’s exact
probability test) and in patients in whom DVT remained at
the time of ﬁlter retrieval (60% in patients with recurrent
VTE vs. 37% in those without VTE; p = 0.3637). In
conclusion, new or recurrent VTE was rare after retrieval
of IVC ﬁlters but was most likely to occur in patients who
had severe DVT during ﬁlter implantation and/or in
patients with a DVT that remained at the time of ﬁlter
retrieval. We must point out that the fatality rate from PE
after ﬁlter removal was high (2.6%).
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Introduction
Although inferior vena cava (IVC) ﬁlter placement is
known to be effective in reducing the risk of pulmonary
embolism (PE) in selected patients [1, 2], when only short-
term protection is required, ideally a permanent IVC ﬁlter
would not be placed, considering the long life expectancy
of such patients [2, 3]. Thus, the use of a temporary vena
cava ﬁlter has found widespread acceptance [4, 5]. How-
ever, problems have been reported, mainly related to the
structure of these devices, in that part of the device projects
from the insertion site [5–7].
On the contrary, no such problems have arisen in the use
of commercially available retrievable ﬁlters, which are
permanent vena cava ﬁlters that can be retrieved when
appropriate. Paralleling the increased usage of retrievable
vena cava ﬁlters in daily clinical practice, reports of their
use have increased [8–14]. However, most published
reports have focused on the feasibility and safety of with-
drawal of the ﬁlter [8–15]. On the other hand, there have
been few large studies on venous thromboembolism (VTE)
after removal of the ﬁlter [16]. The purpose of the present
study was to evaluate the incidence of VTE (VTE; deﬁned
as deep venous thrombosis [DVT] and/or PE) after ﬁlter
retrieval.
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Patients
Between February 2001 and July 2008, at our institution, a
Gunther Tulip retrievable vena cava ﬁlter (GTF) (Cook,
Bjaeverskov, Denmark), which is among the commercially
available retrievable vena cava ﬁlters, was implanted in
163 patients. Removal of the GTF was attempted after
temporal implantation in 81 of these 163 patients, with
successful retrieval in 76 of the 81 patients. (46 women, 30
men; mean age, 59.3 years; range, 18–87 years). These 76
patients comprise the cohort of the present study. In this
retrospective study, data for analysis were obtained through
review of each patient’s chart and results of analysis are
described according to reporting standards recommended
in previous reports [17, 18].
Indications for ﬁlter placement were the existence of PE
and/or DVT in the lower extremities and absolute or rela-
tive contraindication for thrombolysis or anticoagulation
(n = 30), prophylaxis during interventional radiological
treatment such as catheter-directed thrombolysis for lower-
extremity DVT without PE (n = 18), presence of massive
PE with DVT in the lower extremities (n = 12), prophy-
laxis in high-risk patients (remote history of DVT without
acute DVT or PE and need for surgery; n = 10), and no PE
with large, mobile, free-ﬂoating thrombi within the IVC
(n = 6). The distribution of DVT at the time of GTF
implantation in these 76 patients is reported in Table 1.
Sixteen patients had PE before ﬁlter placement. On a
general basis, at our institution, ﬁlter retrieval was
attempted in all cases in which DVT completely or almost
completely disappeared after therapy, the remaining DVT
was limited to veins under the knee, or PE had disappeared
or did not newly develop as revealed on enhanced chest
CT.
GTFs were implanted with the intention of retrieval
within 10–14 days of the initial implantation, which is the
customary period of implantation. When the need to pro-
long temporary caval ﬁltration greatly exceeded 10–
14 days, the period cited in many reports within which a
ﬁlter can be withdrawn safely [3, 11–13, 19], the ﬁrst
implanted GTF was retrieved and another was inserted
near, but not at the same site as, the former GTF [14, 15].
After a vena-cavogram was performed to plan the
position of ﬁlter placement, the GTF was introduced
through the right internal jugular or femoral vein and was
positioned at the cephalad side of the top of the venous
thrombus. The GTF was positioned at the infrarenal IVC in
all but seven patients. Of these seven patients, thrombus in
the IVC distributed at the level of the renal vein in six, and,
in the remaining patient, a huge abdominal tumor com-
pressed the IVC at the infrarenal level, thus the ﬁlter was
placed in the IVC at the suprarenal level. When introduc-
tion of the GTF from the internal jugular vein was difﬁcult
or impossible and insertion from the femoral vein had to be
avoided because of the existence of a DVT on the approach
route, the right subclavian vein was used. The GTF was
placed through the sheath introducer according to the
manufacturer’s instructions. In implanting a GTF, we took
care to orient the ﬁlter so that the hook pointed away from
the contralateral IVC wall, with the open side of the hook
directed toward the IVC lumen.
Retrieval was performed using the GTF retrieval set
supplied by the manufacturer (Cook). Details of the usual
techniques for placement and retrieval of the GTF are
described elsewhere [11, 13, 15]. In cases where a trapped
thrombus ﬁlled one-quarter or more of the height of the
ﬁlter as observed on venography just before retrieval, the
ﬁlter was retrieved only after efforts to diminish the clot.
Examples of such efforts were manual aspiration of the
thrombus using the catheter or sheath introducer inserted
from the femoral vein into the inside of the ﬁlter and
thrombolysis via the catheter introduced into the ﬁlter for
several days.
All procedures were performed by one of ﬁve experi-
enced interventional radiologists at our institution after
written informed consent was obtained from each patient.
Our institution does not require institutional review board
approval for this type of retrospective study. Principles of
the Declaration of Helsinki were followed.
As therapy for VTE before retrieval of GTFs, systemic
anticoagulation was performed in 68 patients. In eight
patients the ﬁlter was retrieved without anticoagulation
because it was placed temporarily for prophylaxis in high-
risk patients undergoing major surgery and VTE did not
develop after surgery in these patients. In 18 cases in which
Table 1 Location of deep venous thrombus in the lower extremities
Thrombus location Number
IVC 8
Iliac
Without extension to IVC 8
With extension to IVC 3
Iliofemoral
Without extension to IVC 4
Iliofemopopliteal
Without extension to calf vein 7
With extension to calf vein 6
With extension to IVC 1
Femoral 4
Femoropopliteal 2
Popliteal—calf 25
None 8
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123DVT was so severe as to be resistant to systemic antico-
agulation therapy alone, an interventional radiological
procedure such as catheter-directed thrombolysis or man-
ual aspiration was added. In all, ultrasound was performed
to detect DVT to decide whether the ﬁlter could be
removed. If sufﬁcient detection of DVT with ultrasound
was difﬁcult, enhanced CT images were added (n = 24). In
all cases with PE (n = 16), enhanced chest CT images
were obtained before deciding on ﬁlter removal. As a
result, there was no DVT in the lower extremities in 47
patients as conﬁrmed by ultrasound and/or enhanced CT
images, while in 29 patients a small area of chronic
thrombophlebitis was present at the time of retrieval of the
ﬁnal ﬁlter. In these 29 patients, the recent phlebitis almost
completely disappeared and no proximal extension of
phlebitis remained as diagnosed by ultrasound and/or
enhanced CT images. The PE disappeared in all patients as
shown on enhanced chest CT.
Follow-Up
All patients were observed at the outpatient clinic at our
institution. They were scheduled to visit the outpatient
clinic every 1–4 months. Differences in the interval
between clinic visits were due to individual circumstances
of each patient, as this study was performed through
analysis of data collected in daily clinical work, not spe-
ciﬁcally for research purposes. During the follow-up per-
iod, hemostasis was monitored by tests that included D-
dimer assays. When one or more of the following was
observed during follow-up, ultrasound and/or enhanced CT
was performed additionally to diagnose VTE every 2–
6 months: (i) VTE remained at the time of ﬁlter retrieval,
(ii) D-dimer increased to[0.5 lg/ml during follow-up, (iii)
symptoms led the physician to suspect the occurrence of
VTE, and (iv) there was a long-term increased risk of VTE
(cancer, n = 7; known hypercoagulable status, n = 2).
Warfarin was administered orally when considered
necessary.
Investigated Parameters
The incidence of development or worsening of VTE was
investigated. Numerous variables were analyzed to assess
risk factors for development or worsening of VTE after
retrieval of GTF. Factors investigated were the patient’s
gender and age, presence of VTE and PE before ﬁlter
placement, interventional therapies for VTE before ﬁlter
retrieval, D-dimer at the time of retrieval, period of ﬁlter
placement, presence of remnant DVT according to ultra-
sound and/or enhanced CT images at the time of ﬁlter
retrieval, and administration of anticoagulation therapy
after ﬁlter retrieval.
Results
Overall, 109 ﬁlters were implanted in 76 patients. The
mean period of implantation of the ﬁlter was 19.7 ± 28.6
(SD) days, ranging from 6 to 264 days. Mean follow-up
period after retrieval of the ﬁlter was 39.8 ± 22.1 months
(range, 6–84 months).
In 5 (6.6%) of the 76 patients in whom the ﬁlter was
retrieved, development or worsening of VTE was seen.
Three (4.0%) had worsening or recurrence of DVT in the
lower extremities that had once completely or almost
completely disappeared, and two (2.6%) had developed PE.
The mortality rate during the follow-up period was 2.6%
(n = 2); both deaths were due to PE.
Table 2 reports the correlation between recurrent VTE
and various risk factors. There were no signiﬁcant differ-
ences in the incidence of redevelopment or worsening of
VTE according to any of the risk factors examined. Table 3
reports the characteristics of ﬁve patients in whom rede-
velopment of VTE was observed during follow-up after
retrieval of the ﬁlter. In cases 3 and 5, PE developed,
resulting in death. In cases 1 and 2 DVT in the femoral and
popliteal veins redeveloped, and in case 4 DVT redevel-
oped in the femoral vein. These three patients had another
thrombolysis-thromboaspiration procedure combined with
insertion of a second retrievable IVC ﬁlter; this second IVC
ﬁlter was left in place for permanent ﬁltration in one
patient. In these three cases, DVT disappeared completely
or almost completely. In summary, among the ﬁve patients
with VTE, two died of PE despite having no potential risk
factor for VTE, and three had severe thrombophlebitis
requiring interventional therapies and also had remnant
thrombus present in calf veins.
Discussion
A multicenter, randomized, open trial of 400 patients with
proximal DVT who were at risk for PE was reported by
Decousus et al. [2]. Of the 400 patients, 200 were ran-
domized to receive a permanent IVC ﬁlter and 200 to
receive no ﬁlter. PE occurred within the ﬁrst 12 days after
randomization in 1.1% of patients who received an IVC
ﬁlter and in 4.8% of patients who received no ﬁlter. These
results showed that the rate of occurrence of symptomatic
or asymptomatic PE initially was signiﬁcantly reduced in
cases with the implanted permanent vena cava ﬁlter com-
pared with those without such a ﬁlter. However, after
2 years, there was no difference in recurrence of PE
between the two groups (3.4% with ﬁlter vs. 6.3% without
ﬁlter). These data suggest that ﬁlters may be most beneﬁ-
cial in the short term. At the 2-year follow-up, the rate of
recurrent DVT was signiﬁcantly higher in patients with the
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123implanted permanent ﬁlter than in those without such a
ﬁlter (20.8% with ﬁlter vs. 11.6% without ﬁlter). Using the
same subjects as in the report of Decousus et al. [2], an 8-
year follow up of patients with permanent vena cava ﬁlters
also showed a moderate increase in DVT in the ﬁlter group
(35.7 vs. 27.5%), while it showed long-term protection by
the vena cava ﬁlter against embolic recurrence (6.2 vs.
15.1%) in the ﬁlter group [20]. Because their insertion is
associated with a signiﬁcant increase in the occurrence of
DVT, the systematic use of permanent vena cava ﬁlters in
the general population with venous VTE is not recom-
mended [20].
Thus, the use of temporary vena cava ﬁlters for a short
time found widespread acceptance in previous periods
beforetheuseofretrievableﬁltersbecamewidespread[4,5].
However, paralleling this increased usage, many reports
havedescribedcomplicationsrelatedtotheirinsertion.Some
were serious and included infection from the part of the
device that protruded from the insertion site [5], air embo-
lism through a defective sheath [5], worsening of proximal
thrombosis along the attached catheter [6], and migration of
the ﬁlter into the pulmonary artery [7]. Moreover, many
temporary ﬁlters require replacement by permanent ﬁlters
[5]becausethemaximalimplantationperiodforthedeviceis
reached before ﬁltering becomes unnecessary.
Considering these above-mentioned complications and
problems with temporary vena cava ﬁlters, a retrievable
ﬁlter that could be implanted without an attached catheter
or guidewire and that also could be used as a permanent
ﬁlter without replacement, if necessary, would offer
advantages. The GTF used in the present study was
developed relatively recently as one such retrievable vena
cava ﬁlter. The ease and safety of insertion of the GTF are
well known [11–13, 21–23], with some reports citing its
use as a nonpermanent ﬁlter [3, 11, 12, 21–23]. Millward
et al. [22] reported that attempts at retrieval were suc-
cessful in 98% of 53 GTFs.
Although the number of reports evaluating retrievability
of retrievable vena cava ﬁlters has been increasing [10, 15,
22, 23], there have been few reports of follow-up of
patients after retrieval [8, 16, 22]. In the report by Millward
et al. [22] describing a mean follow-up of 103 days, DVT
recurred in 1 (2.7%) of 37 patients in whom the ﬁlter was
removed. Asch et al. [8] reported that 1 (4.5%) PE
occurred among 22 patients during a postretrieval clinical
follow-up of an average of 223 days with Recovery ﬁlters.
Yavuz et al. [16] reported results of follow-up after
retrieval of 72 ﬁlters implanted in 67 patients. The mean
follow-up period in their study was 20.6 months, and
recurrent DVT was seen in 2 (2.8%) patients.
In our study, the rate of recurrent PE was 2.0% and that
of DVT was 4.6%. The incidence of recurrent VTE in our
study was similar to that in previous studies, although the
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123follow-up period was much longer and the number of
patients was larger than in the previous reports [8, 16, 22].
In our series, the mean follow-up period after retrieval of
the ﬁlter was 39.8 ± 22.1 months (range, 6–84 months).
Such good results might be due to careful long-term
observation at the outpatient clinic after ﬁlter removal with
imaging modalities such as ultrasound and enhanced CT
and with blood tests such as D-dimer assays. Among risk
factors for recurrent VTE after ﬁlter removal, which were
not investigated previously to our knowledge, we found
that there was a tendency for recurrence of VTE at a higher
rate in cases in whom the status of DVT before ﬁlter
implantation was severe and in whom DVT remained at the
time of ﬁlter removal. However, the difference was not
statistically signiﬁcant.
However, the fact that two patients died due to recurrent
PE in our study suggests the importance of caution
regarding indications for ﬁlter retrieval and clinical follow-
up after removal, although analysis revealed that they had
no particular risk factor except for the interruption of
anticoagulation in one of these cases. Considering that
retrievable IVC ﬁlters are currently used very widely,
randomized and prospective studies with large numbers of
subjects would be necessary to determine indications for
removal of retrievable IVC ﬁlters.
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